1984
DOI: 10.1159/000299155
|View full text |Cite
|
Sign up to set email alerts
|

Gardnerella-Associated Vaginitis and Anaerobic Bacteria

Abstract: 12 patients with mild or moderate symptoms of Gardnerella-associated vaginitis were examined clinically and microbiologically on 52 different occasions, 27 of which were asymptomatic. The symptomatic state was defined by fulfilling at least three of the following criteria: (1) subjective symptoms; (2) pH above 4.5; (3) positive amine test, and (4) clue cells in wet smear. Variation of the vaginal microflora was considerable. No causative bacterial species could be identified. Microorganisms of the genus Bacter… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
18
0

Year Published

1987
1987
2009
2009

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(19 citation statements)
references
References 9 publications
(12 reference statements)
1
18
0
Order By: Relevance
“…The explanation for the myriad of findings in patients with BV remains incomplete, although considerable progress has been made in understanding aspects of the pathogenic process (5,7,9,25,27,28). BV is thought to represent a massive overgrowth of vaginal microorganisms, primarily anaerobic gram-positive cocci and gram-negative bacilli, including Prevotella species, Gardnerella vaginalis, and Mobiluncus species (13,19,23,26,30).Published studies indicate that the drug of choice for therapy of BV is oral metronidazole; therapeutic success is achieved in 85 to 90% of patients with this therapy (10). Treatment with metronidazole is followed by eradication of the anaerobes and G. vaginalis together with alleviation of symptoms (4,22).…”
mentioning
confidence: 99%
“…The explanation for the myriad of findings in patients with BV remains incomplete, although considerable progress has been made in understanding aspects of the pathogenic process (5,7,9,25,27,28). BV is thought to represent a massive overgrowth of vaginal microorganisms, primarily anaerobic gram-positive cocci and gram-negative bacilli, including Prevotella species, Gardnerella vaginalis, and Mobiluncus species (13,19,23,26,30).Published studies indicate that the drug of choice for therapy of BV is oral metronidazole; therapeutic success is achieved in 85 to 90% of patients with this therapy (10). Treatment with metronidazole is followed by eradication of the anaerobes and G. vaginalis together with alleviation of symptoms (4,22).…”
mentioning
confidence: 99%
“…This is to some extent remarkable although not clinically acceptable, par ticularly since metronidazole has given cure rates of about 80% in our hands employing identical criteria [3][4][5][6]. Of course, the present study was not designed to define treat ment efficacy with this drug, but it may be of interest that in a previous study [3] treatment with three different vagi nal preparations other than metronidazole cured only 5 out of 43 patients.…”
Section: Discussionmentioning
confidence: 69%
“…Colonization with lactobacilli capable of hydrogen per oxide production [16,17] with BV. This prompted us to reexamine our protocols of all the cases reported upon previously [3][4][5][6], Among those lactobacilli recognized to produce HyCb [15,16], 15 iso lates of L. jensenii were found in women without symp toms and only 1 in a woman with BV. L. rogosae was the second most common with 10 isolates in healthy versus 2 in symptomatic women.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Many reports have claimed that BV is an expres sion of a disturbed vaginal ecology with loss of the natural predominance of lactobacilli rather than an infection with pathogenic mi croorganisms [4][5][6][7], With this in mind it would be superfluous to prescribe potent an tibiotics orally for longer or shorter periods even with a relatively innocent drug. Conse quently, treatment with vaginal tablets of metronidazole has been suggested and found to have equal clinical efficacy as oral treat ment [8].…”
Section: Introductionmentioning
confidence: 99%